ESCRS - PO273 - Posner Schlossman Syndrome; When Ocular Hypertension Is Unilateral, Know It Or Lose It!

Posner Schlossman Syndrome; When Ocular Hypertension Is Unilateral, Know It Or Lose It!

Published 2022 - 40th Congress of the ESCRS

Reference: PO273 | Type: ESCRS 2022 - Posters | DOI: 10.82333/f2yp-f066

Authors: Meryam Smiri* 1 , Hind Hamdani 2 , Amer Al Sanharawi 3 , Ruba Bousmaille 2 , Ruxandra Dina 1 , Mohamed Amine Khoudrani 1 , Abdeldjalil Mansouri 1 , Mohamed El Sanharawi 1

1Ophthalmology,chateaudun hospital,Châteaudun,France, 2chateaudun hospital,Châteaudun,France;Ophthalmology,chateaudun hospital,Châteaudun,France, 3chateaudun hospital ,Châteaudun,France;Ophthalmology,chateaudun hospital,Châteaudun,France

Purpose

Posner Schlossman syndrome is a rare entity and a sight threatening condition, frequently associated with acute, unilateral, elevated intraocular pressure (IOP) and mild anterior chamber inflammation. It was originally considered benign but is now recognized as a relatively rare and yet serious cause of secondary glaucoma. While its etiology is still uncertain, it is essential to be aware of its characteristics, in order to prevent long-term secondary inflammatory glaucoma.

Setting

Ophthalmology Emergency Department, Châteaudun Hospital, France.

Methods

We report the case of a 45 years old male presented in our emergency department after weeks of blurred vision in his right eye and intermittent frontal headaches.

Results

The ophtalmological examination revealed a visual acuity of 6/10 on the right and 10/10 on the left eye. The intraocular pressure was 40 mmHg on the right and 17mmHg on the left eye. Slit lamp examination was unremarkable on the left. On the right eye, it revealed a mild corneal oedema, small white round keratic precipitates, no sign of anterior chamber inflammation, and discrete anisocoria. The fundus examination was normal. Initial treatment was based on the control of the intraocular pressure including topical beta-blockers, alpha-agonists, and carbonic anhydrase inhibitors. Antiviral drugs (Valganciclovir) has also been advocated as a first-line agent The clinical evolution was satisfactory.

Conclusions

Posner Schlossman syndrome also known as glaucomatocyclitic crisis is a rare disease with clinical diagnosis. In the absence of etiological treatment, early management remains essential in the prevention of complications that may affect the visual prognosis, and the development of permanent vision loss due to glaucomatous optic nerve damage. Regular follow-up with IOP monitoring, visual field evaluation and optic nerve examination are important to ensure no glaucoma progression.